nach oben

Erschienen in:

01.04.2024 | News item

Drug interactions between Paxlovid and immunosuppressants

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

The Health Products Regulatory Authority (HPRA) in Ireland has published a Direct Healthcare Professional Communication from Pfizer Healthcare Ireland to remind healthcare professionals of life-threatening and fatal drug interactions between Paxlovid (nirmatrelvir/ritonavir) and some immunosuppressants. …

PAXLOVID ? (nirmatrelvir; ritonavir): reminder of life-threatening and fatal drug-drug interactions with certain immunosuppressants, including tacrolimus Internet Document : 20 Mar 2024. Available from: URL: https://www.hpra.ie/homepage/medicines/safety-notices/item?t=/paxlovid-(nirmatrelvir-ritonavir)---important-safety-information-from-pfizer-healthcare-ireland-as-approved-by-the-hpra-(21.03.24)&id=c2aa1526-9782-6eee-9b55-ff00008c97d0

Titel: Drug interactions between Paxlovid and immunosuppressants
Publikationsdatum: 01.04.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55382-x

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Drug interactions between Paxlovid and immunosuppressants

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Iodine-radioactive

Paclitaxel/erlotinib/gemcitabine

Eculizumab/immune-globulin/methylprednisolone

Carbamazepine overdose

Antineoplastics

Multiple drugs